FocusRheumatoid Arthritis

Sclerostin: More than a bone formation brake

See allHide authors and affiliations

Science Translational Medicine  16 Mar 2016:
Vol. 8, Issue 330, pp. 330fs7
DOI: 10.1126/scitranslmed.aaf4628

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Anti-sclerostin treatment spurs an unexpected acceleration of bone erosion in a mouse model of rheumatoid arthritis (Wehmeyer et al., this issue).

View Full Text

Stay Connected to Science Translational Medicine

Editor's Blog